Discover 1,576 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,576
Active & Responsive
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
Location: Jersey City NJ, Newark NJ, Queens NY, Manhasset NY,
Sponsor: TherOx
Sex: All
Age: 18 - 70+
Code: NCT06438315
Recruiting
Periprosthetic Fracture Registry (PPFx)
for
Periprosthetic Fractures,
Location: Jersey City NJ, Livingston NJ, Nashville TN,
Sponsor: AO Innovation Translation Center
Sex: All
Age: 18+
Code: NCT03378557
Recruiting
Tumor Grade Determines PD-1/PDL-1 Expression
for
Endometrial Cancer, Ovarian Cancer
Location: Jersey City NJ
Sponsor: RWJ Barnabas Health at Jersey City Medical Center
Sex: Female
Age: 0+
Code: NCT04528940
Recruiting
Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer
for
Colon Cancer, Rectal Cancer
Location: Jersey City NJ, Elizabeth NJ, Livingston NJ,
Sponsor: Rutgers, The State University of New Jersey
Sex: All
Age: 18+
Code: NCT05806931
Phase 2, Recruiting
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Jersey City NJ, New York NY, Brooklyn NY, Belleville NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07391774
Phase 3, Recruiting
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
for
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Jersey City NJ, Newark NJ, Livingston NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07195734
Phase 2, Recruiting
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
for
Locally Advanced Cervical Adenocarcinoma,
Location: Jersey City NJ, New York NY, Newark NJ,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07061977
Phase 3, Recruiting
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Location: Jersey City NJ, New York NY, Livingston NJ,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 65+
Code: NCT07321652
Phase 3, Recruiting
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Jersey City NJ, New York NY, Flushing NY, Livingston NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07061964
Phase 2, Recruiting
Lynch Syndrome Can be Diagnosed Just From Somatic Mismatch Repair Mutation
for
Cancer Gene Mutation, Lynch Syndrome, Endometrial Cancer,
Location: Jersey City NJ
Sponsor: RWJ Barnabas Health at Jersey City Medical Center
Sex: Female
Age: 0+
Code: NCT04516083
Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
for
Ovarian Carcinoma
Location: Jersey City NJ, New York NY, Newark NJ, Rego Park NY,
Sponsor: NRG Oncology
Sex: Female
Age: 35 - 50
Code: NCT04251052
Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Jersey City NJ, New York NY, Montvale NJ, Uniondale NY,